NOVEMBER 6th - BROKERAGE
EVENT
14.00 - 18.00 Technology and projects brokerage
event (organised by ALPS and SOFRAA IRCs)
NOVEMBER
7th
08.00 - 09.00 Registration
09.00 - 09.45 Opening Plenary
Session
- Giorgio Trinchieri: Laboratory of Experimental
Immunology, National Cancer Institute, USA
Dendritic Cells
and their Cytokines at the interface of Inflammation and
Immunity
:: MORNING :: 09.45
- 12.30
Two Parallel Sessions (coffee break at 11.00) |
Session
A : Signal Trasduction in Inflammation and Autoimmunity
Chairmen: Santo Landolfo, Italy
- Andrès McAllister, Switzerland |
Keynote Lecture:
- Anthony Coyle: MedImmune Inc, USA
New Therapeutic Approaches for
the Treatment of Autoimmune disorders: targeting B
Cells, Dendritic Cells and Type I Interferons
- Umberto Dianzani: Science of Medicine
Department, “Piemonte Orientale” University,
Italy
Inherited defects of the Immune
Response switching off System in Autoimmunity
- Marie-Josèphe RABIET: CEA
Grenoble-iRSTV, Laboratoire de Biochimie et Biophysique
des Systèmes intégrés, France
Phagocyte chemoattractant Receptors:
peptide-induced activation, signalling and regulation
- Izui Shozo: Dept. of Pathology
and Immunology, Centre Hospitalier Universitaire Genève,
Switzerland
The emerging Role of Toll-like
Receptors in Murine SLE
|
Session
B : Tissue-specific Autoimmunity (Liver, Cardiovascular,
Skin, Kidney)
Chairmen: Bernard Mach, Switzerland
- Patrice Marche, France |
Keynote Lecture:
- Luciano Adorini: Chief Scientific Officer
of BioXell, Italy
Vitamin D receptor agonists as
antiinflammatory agents in tissue-specific autoimmunity
- Silvio Traversa: Chief Scientific
Officer, Creabilis Therapeutics, Italy
A novel therapeutic approach
in psoriasis treatment
- Ennio Ongini: Nicox Research Institute
Srl, Italy
Anti-Inflammatory Properties
of a new class of Nitric Oxide (NO) donating Statins
- Françoise Morel: Enzymology
Laboratory, CHU Grenoble, France
The NADPH oxidases Nox new therapeutic
target in Inflammatory Diseases
|
12.30 - 14.30 Lunch Break and Poster
Session : Young academic Researchers (under 35) and
young start-ups (no more than 3 years old) present a poster
about their research findings related to the topic of Inflammation
and Autoimmunity and the best will be awarded a money prize.
The main evaluation criteria will be scientific quality
and industrial related application.
:: AFTERNOON :: 14.30
- 17.00
Two Parallel Sessions (coffee break at 16.00) |
Session
C : Diagnostics and Biomarkers
Chairmen: Gianni Garotta, Italy
- Benôit Polack, France |
Keynote Lecture:
- Fabio Malavasi: Institute of Genetics,
University of Turin, Italy
Leucocyte surface molecules,
immune response and diseases
- Giovanni Rolla: Dept. of Immunology
and Allergology, ASO Ordine Mauriziano, Italy
Disease markers in exhaled air:
from Asthma to Transplant
- Karl-Heinz Krause: Pathology &
Immunology Depts, Centre Medical Universitaire Genève,
Switzerland
NOX Enzymes and Autoimmunity:
from mice to men
- Nicolas Pasqual: C.E.O ImmunID
Technologies, France
ImmunTraCkeR, the T & B cell
repertoire forecast: a personalized diagnostic tool
of immune diseases dedicated to the monitoring of
treatment efficiency
|
Session
D : Therapy
Chairmen: Santo Landolfo, Italy
- François Spertini, Switzerland |
Keynote Lecture:
- Fred Hammel: TxCell Controlled Immunity,
Sophia Antipolis, France
Clinical pathway for Tr1 cellular
therapy to provide a curative Treatment for Autoimmune
Diseases and chronic Inflammations
- Marco E. Bianchi:
Department
of Biotechnology, San Raffaele Hospital, Italy
HMGB1 at the crossroads
between native and adaptive Immunity: a possible target
for the Therapy of Autoimmune Diseases
- Hervé Perron:
GeNeuro S.A., Switzerland
Monoclonal Antibody against
ENV protein from human endogenous retrovirus “W”
inhibits TLR4-initated immunotoxicity cascade in human
peripheral blood mononuclear cells and displays therapeutic
effects in novel pre-clinical models for Multiple
Sclerosis
- Claudia Pena Rossi:
Merck Serono SA, New Therapies Clinical Development
Unit, Switzerland
Novel B-cell targeted therapies
in Autoimmune Disease
|
17.00 - 18.00 Closing Plenary
Session and Poster Award Ceremony
|
